Showing results (31-40 of 164) with videos related to
Sort By:
Pageof 17
Leukemia & Lymphoma|July 12, 2016
Epidemiology of invasive fungal infections during induction therapy in adults with acute lymphoblastic leukemia: a GRAALL-2005 studyClara Mariette, Emmanuelle Tavernier, Didier Hocquet, et al.Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|December 3, 2014
Human metapneumovirus pneumonia in patients with hematological malignanciesCendrine Godet, Jérôme Le Goff, Agnès Beby-Defaux, et al.Blood|September 28, 2002
Favorable prognostic significance of CEBPA mutations in patients with de novo acute myeloid leukemia: a study from the Acute Leukemia French Association (ALFA)Claude Preudhomme, Christophe Sagot, Nicolas Boissel, et al.Annals of Hematology|February 11, 2023
Benefits of dexamethasone on early outcomes in patients with acute myeloid leukemia with hyperleukocytosis: a propensity score matched analysisMarco Cerrano, Sylvie Chevret, Emmanuel Raffoux, et al.Cancer|October 27, 2020
Phase 1 study to evaluate Crenigacestat (LY3039478) in combination with dexamethasone in patients with T-cell acute lymphoblastic leukemia and lymphomaGautam Borthakur, Giovanni Martinelli, Emmanuel Raffoux, et al.Open Forum Infectious Diseases|March 31, 2022
Hepatosplenic Candidiasis in Patients With Hematological Malignancies: A 13-Year Retrospective Cohort StudyInès Boussen, Quentin Lisan, Emmanuel Raffoux, et al.Leukemia Research|August 20, 2013
Combination of vorinostat and low dose cytarabine for patients with azacitidine-refractory/relapsed high risk myelodysplastic syndromesThomas Prebet, Thorsten Braun, Odile Beyne-Rauzy, et al.Oncotarget|October 15, 2013
High imatinib dose overcomes insufficient response associated with ABCG2 haplotype in chronic myelogenous leukemia patientsMarc Delord, Philippe Rousselot, Jean Michel Cayuela, et al.Transfusion|March 15, 2006
Prospective flow cytometric evaluation of nucleated red blood cells in cord blood units and relationship with nucleated and CD34(+) cell quantificationJerome Larghero, Delphine Rea, Yves Brossard, et al.Plos One|July 7, 2022
Post-remission outcomes in AML patients with high hyperleukocytosis and inaugural life-threatening complicationsSofiane Fodil, Sylvie Chevret, Camille Rouzaud, et al.Pageof 17